Cardiac cholinergic NO-cGMP signaling following acute myocardial infarction and nNOS gene transfer.

Cardiac cholinergic NO-cGMP signaling following acute myocardial infarction and nNOS gene transfer.

Myocardial infarction (MI) is associated with oxidative stress, which may cause cardiac autonomic impairment. We tested the hypothesis that acute MI disrupts cardiac cholinergic signaling by impairing nitric oxide (NO)-cGMP modulation of acetylcholine (ACh) release and whether the restoration of thi...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Dawson, T, Li, D, Woodward, T, Barber, Z, Wang, L, Paterson, D
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	2008

Παρόμοια τεκμήρια

Myocardial nNOS-derived NO regulates excitation-contraction coupling via differential and cGMP-independent effects on protein phosphorylation
ανά: Zhang, M, κ.ά.
Έκδοση: (2012)

Targeted nNOS gene transfer into the cardiac vagus rapidly increases parasympathetic function in the pig.
ανά: Heaton, D, κ.ά.
Έκδοση: (2005)

NO-cGMP pathway facilitates vagal neurotransmission and bradycardia
ανά: Herring, N, κ.ά.
Έκδοση: (2001)

Impaired cAMP-cGMP cross-talk during cardiac sympathetic dysautonomia.
ανά: Bardsley, E, κ.ά.
Έκδοση: (2016)

Cardiac nNOS regulates myocardial relaxation by stimulating phospholamban phosphorylation
ανά: Zhang, Y, κ.ά.
Έκδοση: (2005)

Cardiac nNOS regulates myocardial relaxation by stimulating phospholamban phosphorylation
ανά: Zhang, Y, κ.ά.
Έκδοση: (2005)

nNOS gene deletion exacerbates pathological left ventricular remodeling and functional deterioration after myocardial infarction
ανά: Dawson, D, κ.ά.
Έκδοση: (2005)

nNOS gene deletion exacerbates pathological left ventricular remodelling and functional deterioration after myocardial infarction
ανά: Dawson, D, κ.ά.
Έκδοση: (2005)

nNOS gene deletion exacerbates pathological left ventricular remodeling and functional deterioration after myocardial infarction.
ανά: Dawson, D, κ.ά.
Έκδοση: (2005)

cGMP catabolism by phosphodiesterase 5A regulates cardiac adrenergic stimulation by NOS3-dependent mechanism.
ανά: Takimoto, E, κ.ά.
Έκδοση: (2005)

Natriuretic peptides like NO facilitate cardiac vagal neurotransmission and bradycardia via a cGMP pathway.
ανά: Herring, N, κ.ά.
Έκδοση: (2001)

Adenoviral nNOS gene transfer into the cardiac vagus increases protein expression within 9 hours and enhances vagal responsiveness in the pig
ανά: Paterson, D, κ.ά.
Έκδοση: (2004)

NO-cGMP dependent pathway and the modulation of vagal control of heart rate
ανά: Herring, N, κ.ά.
Έκδοση: (2000)

Cardiac nitric oxide: emerging role for nNOS in regulating physiological function.
ανά: Danson, E, κ.ά.
Έκδοση: (2005)

Discordant response to exercise training in nnos knockout mice: Differential role of nNOS on exercise performance versus cardiac hypertrophy
ανά: de Bono, J, κ.ά.
Έκδοση: (2007)

FRET-based cyclic GMP biosensors measure low cGMP concentrations in cardiomyocytes and neurons
ανά: Calamera, G, κ.ά.
Έκδοση: (2019)

FRET-based cyclic GMP biosensors measure low cGMP concentrations in cardiomyocytes and neurons
ανά: Calamera, G, κ.ά.
Έκδοση: (2019)

Possible regulation of cardiac ADP-ribosyl cyclase by cGMP-dependent mechanisms
ανά: Solanki, P, κ.ά.
Έκδοση: (2000)

Sulphonylurea-sensitive channels and NO-cGMP pathway modulate the heart rate response to vagal nerve stimulation in vitro.
ανά: Almond, S, κ.ά.
Έκδοση: (2000)

Role of nNOS in the automatic control of cardiac excitability in cardiac physiological and pathophysiological states
ανά: Heaton, D, κ.ά.
Έκδοση: (2005)

Activation of sulphonylurea-sensitive channels and the NO-cGMP pathway decreases the heart rate response to sympathetic nerve stimulation.
ανά: Mohan, R, κ.ά.
Έκδοση: (2000)

Selective gene deletion of the neuronal nitric oxide synthase (nNOS) accelerates pathological left ventricular remodelling and functional deterioration after myocardial infarction (MI)
ανά: Dawson, D, κ.ά.
Έκδοση: (2005)

Effect of disruption of the nNOS gene on myocardial calcium current and contraction
ανά: Sears, C, κ.ά.
Έκδοση: (2001)

Nutraceutical COMP-4 confers protection against endothelial dysfunction through the eNOS/iNOS-NO-cGMP pathway.
ανά: Monica G Ferrini, κ.ά.
Έκδοση: (2025-01-01)

Association between left ventricular reverse remodelling and the B-type natriuretic peptide–cGMP cascade after anterior acute myocardial infarction
ανά: Satoshi Yasuda, κ.ά.
Έκδοση: (2025-01-01)

cAMP and cGMP signaling cross-talk: role of phosphodiesterases and implications for cardiac pathophysiology.
ανά: Zaccolo, M, κ.ά.
Έκδοση: (2007)

NO-cGMP pathway increases the hyperpolarisation-activated current, I(f), and heart rate during adrenergic stimulation.
ανά: Herring, N, κ.ά.
Έκδοση: (2001)

L-NAME causes antinociception by stimulation of the arginine-NO-cGMP pathway
ανά: I. D. G. Duarte, κ.ά.
Έκδοση: (2000-01-01)

Pre-synaptic NO-cGMP pathway modulates vagal control of heart rate in isolated adult guinea pig atria.
ανά: Herring, N, κ.ά.
Έκδοση: (2000)

Constitutive NO production in the myocardium: More than cGMP signalling
ανά: Casadei, B
Έκδοση: (2008)

Role of the NO-GC/cGMP signaling pathway in platelet biomechanics
ανά: Aylin Balmes, κ.ά.
Έκδοση: (2024-12-01)

Effectiveness of NO-cGMP axis for lower urinary tract syndrome
ανά: Yukihide Matsui, κ.ά.
Έκδοση: (2016-06-01)

Reduced phospholamban phosphorylation is responsible for impaired myocardial relaxation in nNOS(-/-) mice
ανά: Zhang, Y, κ.ά.
Έκδοση: (2006)

Reduced phospholamban phosphorylation is responsible for impaired myocardial relaxation in nNOS(-/-) mice
ανά: Zhang, Y, κ.ά.
Έκδοση: (2005)

Nitric oxide-cGMP pathway facilitates acetylcholine release and bradycardia during vagal nerve stimulation in the guinea-pig in vitro.
ανά: Herring, N, κ.ά.
Έκδοση: (2001)

Differential role of nNOS in heart rate regulation between rest and exercise
ανά: Adlam, D, κ.ά.
Έκδοση: (2007)

Sodium channel and nNOS expression following inferior alveolar nerve
ανά: Davies, S, κ.ά.
Έκδοση: (2001)

nNOS expression following inferior alveolar nerve injury in the ferret.
ανά: Davies, S, κ.ά.
Έκδοση: (2004)

Compartmentalized phosphodiesterase-2 activity blunts beta-adrenergic cardiac inotropy via an NO/cGMP-dependent pathway.
ανά: Mongillo, M, κ.ά.
Έκδοση: (2006)

Role of cGMP-inhibited phosphodiesterase and sarcoplasmic calcium in mediating the increase in basal heart rate with nitric oxide donors.
ανά: Musialek, P, κ.ά.
Έκδοση: (2000)